Skip to main content
Clinical Trials/NL-OMON32776
NL-OMON32776
Completed
Phase 2

Deep Brain Stimulation in Treatment-refractory patients with Major Depressive Disorder; A pilot study - DBS in Depression

Academisch Medisch Centrum0 sites25 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Major Depressive Disorder
Sponsor
Academisch Medisch Centrum
Enrollment
25
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
August 2, 2016
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Primary diagnosis: MDD (single episode or recurrent; 296\.2 or 296\.3\) according to the DSM\-IV criteria based on a psychiatric interview and the SCID as diagnostic instrument
  • \- Illness duration \> 2 years, chronic MDD
  • \- HAM\-D total above or equal : 18 (measured twice, at least two weeks apart with the last assessment just before surgery)
  • \- Disabling severity with substantial functional impairment according to the DSM\-IV criterion C and a Global Assessment of Function (GAF) score of 45 or less
  • \- The level of impairment must have been persistent for at least 2 years
  • \- Age: 18\-65 years old
  • \- Written informed consent
  • \- Able to fully understand the consequences of the procedure (IQ \> 80\)
  • \- Dutch or English speaking and able to answer the study questions
  • \- Capable to make his or her own choice without coercion

Exclusion Criteria

  • \- Unstable physical condition
  • \- Organic cause
  • \- Parkinson\*s disease, dementia, epilepsy
  • \- Schizophrenia /history of psychosis unrelated to MDD
  • \- Alcohol or substance abuse (including benzodiazepines) during last 6 months
  • \- Current Tic disorder
  • \- Antisocial personality disorder
  • \- Bipolar Disorder
  • \- Pregnancy
  • \- Mental retardation

Outcomes

Primary Outcomes

Not specified

Similar Trials